Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Clarivate Analytics Plc (NY: CLVT )

6.220 -0.030 (-0.48%)
Official Closing Price Updated: 4:10 PM EDT, May 13, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Clarivate Analytics Plc

< Previous 1 2 3 4 5 6 7 Next >
What 5 Analyst Ratings Have To Say About Clarivate
Via Benzinga
Clarivate Is Oversold Stock Brimming with Turnaround Potential, Analyst Predicts
Oppenheimer analyst Owen Lau initiates coverage on Clarivate Plc (NYSE: CLVT) with an Outperform rating and  
Via Benzinga
Where Clarivate Stands With Analysts
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 13, 2023
Via Benzinga
Analyst Expectations for Clarivate's Future
Via Benzinga
The Latest Analyst Ratings for Clarivate
Via Benzinga
Earnings Scheduled For March 1, 2023
Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million. 
Via Benzinga
Expert Ratings for Clarivate
Via Benzinga
Expert Ratings for Clarivate
Clarivate (NYSE:CLVT) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  On Monday, 61 companies hit new 52-week lows. 
Via Benzinga
12 Industrials Stocks Moving In Wednesday's Intraday Session
Via Benzinga
3D Systems, CarGurus, Sarepta Therapeutics And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded lower, with the Dow Jones dropping around 80 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Where Clarivate Stands With Analysts
Clarivate (NYSE:CLVT) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia. 
Via Benzinga
Analyst Ratings for Clarivate
Clarivate (NYSE:CLVT) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Morgan Stanley Maintains Overweight Rating for Clarivate: Here's What You Need To Know
Morgan Stanley has decided to maintain its Overweight rating of Clarivate (NYSE:CLVT) and lower its price target from $16.00 to $15.00. Shares of Clarivate are trading down 2.75% over the last 24... 
Via Benzinga
5 Analysts Have This to Say About Clarivate
Analysts have provided the following ratings for Clarivate (NYSE:CLVT) within the last quarter: 
Via Benzinga
What 5 Analyst Ratings Have To Say About Clarivate
  Analysts have provided the following ratings for Clarivate (NYSE:CLVT) within the last quarter: 
Via Benzinga
Recap: Clarivate Q2 Earnings
  Clarivate (NYSE:CLVT) reported its Q2 earnings results on Tuesday, August 9, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 6, 2023
Via Benzinga
Singapore's National Library Board Picks Clarivate's Software Solutions To Support LAB25 Initiative
Via Benzinga
12 Industrials Stocks Moving In Monday's Pre-Market Session
  
Via Benzinga
Clarivate: Q1 Earnings Insights
Clarivate (NYSE:CLVT) reported its Q1 earnings results on Monday, May 9, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
What 4 Analyst Ratings Have To Say About Clarivate
Within the last quarter, Clarivate (NYSE:CLVT) has observed the following analyst ratings: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2022
Upgrades 
Via Benzinga
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Clarivate Plc with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
CLARIVATE INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates Clarivate’s Plc’s Directors for Breach of Fiduciary Duties – CLVT
From Scott+Scott Attorneys at Law LLP
Via Business Wire
10 Industrials Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
12 Industrials Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Clarivate Plc (NYSE:CLVT) Long Term Investor Notice: Investigation over Possible Wrongdoing
San Diego, CA -- (SBWIRE) -- 05/16/2022 -- Certain directors of Clarivate Plc are under investigation over potential breaches of fiduciary duties. 
Via SBWire
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.